Role of the CTCF binding site in Human T-Cell Leukemia Virus-1 pathogenesis
During HTLV-1 infection, the virus integrates into the host cell genome as a provirus with a single CCCTC binding protein (CTCF) binding site (vCTCF-BS), which acts as an insulator between transcriptionally active and inactive regions. Previous studies have shown that the vCTCF-BS is important for maintenance of chromatin structure, regulation of viral expression, and DNA and histone methylation. Here, we show that the vCTCF-BS also regulates viral infection and pathogenesis in vivo in a humanized (Hu) mouse model of adult T-cell leukemia/lymphoma. Three cell lines were used to initiate infection of the Hu-mice, i) HTLV-1-WT which carries an intact HTLV-1 provirus genome, ii) HTLV-1-CTCF, which contains a provirus with a mutated vCTCF-BS which abolishes CTCF binding, and a stop codon immediately upstream of the mutated vCTCF-BS which deletes the last 23 amino acids of the p12 gene, and iii) HTLV-1-p12stop that contains the intact vCTCF-BS, but retains the same stop codon in p12 as in the HTLV-1-CTCF cell line. Hu-mice were infected with mitomycin-treated or irradiated HTLV-1 producing cell lines. There was a delay in pathogenicity when Hu-mice were infected with the HTLV-1-CTCF virus compared to mice infected with either HTLV-1-p12 stop or HTLV-1-WT virus. Proviral load (PVL), spleen weights, and CD4 T cell counts were significantly lower in HTLV-1-CTCF infected mice compared to HTLV-1-p12stop infected mice. Furthermore, we found a direct correlation between the PVL in peripheral blood and death of HTLV-1-CTCF infected mice. In cell lines, we found that the vCTCF-BS regulates Tax expression in a time-dependent manner. The scRNAseq analysis of splenocytes from infected mice suggests that the vCTCF-BS plays an important role in activation and expansion of T lymphocytes in vivo. Overall, these findings indicate that the vCTCF-BS regulates Tax expression, proviral load, and HTLV pathogenicity in vivo.
Authors
- John C. S. Harding (ORCID: https://orcid.org/0000-0002-8741-0402)
- Patrick Green (ORCID: https://orcid.org/0000-0002-4805-7298)
- Malachi Griffith (ORCID: https://orcid.org/0000-0002-6388-446X)
- Jacob Al-Saleem (ORCID: https://orcid.org/0000-0001-8929-7098)
- Ancy Joseph (ORCID: https://orcid.org/0000-0001-7371-1696)
- Lee Ratner (ORCID: https://orcid.org/0000-0003-2744-7294)
- Daniel A. Rauch (ORCID: https://orcid.org/0000-0003-4714-8339)
- Xiaogang Cheng (ORCID: https://orcid.org/0000-0002-5343-0990)
- Deborah J. Veis
Institutions
- Washington University in St. Louis (US)
- The Ohio State University (US)
Publication Details
- Journal
- PLoS Pathogens
- Published
- 2025-06-03
- DOI
- https://doi.org/10.1371/journal.ppat.1012293
- Primary Topic
- T-cell and Retrovirus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Cancer Institute